company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9188000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9188000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9188000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6601000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19897000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26498000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17310000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,44000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,189000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17165000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17310000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-44000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-17165000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17209000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-73000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17136000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97642330.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97642330.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95200000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 08:10:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9059000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9059000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9059000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6482000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18742000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16165000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,81000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,188000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,107000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16058000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2944000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13114000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6367000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6747000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1523000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8270000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97925657.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97925657.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:32:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12218000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12218000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12218000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10929000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22905000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33834000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21616000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,897000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,986000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20630000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,20633000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100174100.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100174100.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:16:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52628000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52628000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52628000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14962000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20474000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59660000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7032000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37245000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37187000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44219000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-20633000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64852000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64852000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-18844000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46008000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99874790.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12248000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12248000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12248000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16319000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29510000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2055000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47884000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35636000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35601000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,35636000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103751060.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q1,2012-01-01,2012-03-31,2013-04-23 14:15:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14604000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14604000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14604000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20099000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32238000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3101000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55438000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40834000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,40803000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40834000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107078150.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107078150.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107078150.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:06:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96413000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96413000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,96413000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22846000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23453000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2506000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48805000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47608000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47635000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47635000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47635000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47635000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107266823.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114337327.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q3,2012-07-01,2012-09-30,2013-10-28 16:06:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26980000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26980000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,965000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,965000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26015000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33274000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28273000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8368000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69915000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43900000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-76404000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-76359000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-120259000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120259000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120259000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-120259000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.12
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106402639.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3255000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3255000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1231000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1231000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2024000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33374000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32753000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,24730000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90857000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-88833000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5121000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,93902000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88833000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108072643.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q1,2013-01-01,2013-03-31,2013-04-23 14:15:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.87
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9663000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9663000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3418000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3418000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6245000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30870000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24093000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11162000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66125000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59880000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5318000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,65149000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59880000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113441391.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113441391.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113441391.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:06:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4932000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4932000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2021000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2021000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2911000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30264000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23016000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6182000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59462000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56551000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5265000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61775000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61775000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61775000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61775000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,121100000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121100000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120769000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:06:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5031000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5031000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,533000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,533000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4498000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28720000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22516000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51236000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46738000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5298000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-159051000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-164299000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-211037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-211037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-211037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-211037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,116100000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.84
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116100000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.84
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115852000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14605000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14605000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1924000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1924000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12681000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29924000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27144000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57068000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44387000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5283000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5239000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49626000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49626000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49626000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49626000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129745000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6840000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6840000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10518000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10518000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-3678000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29299000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22142000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51441000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-55119000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5303000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5238000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60357000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60357000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60357000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-60357000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137200000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137200000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,138315000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:16:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16918000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16918000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16918000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28535000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25122000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53657000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36739000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5320000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5249000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41988000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41988000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41988000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41988000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,140000000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,140000000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139234000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q3,2014-07-01,2014-09-30,2014-11-05 16:06:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38073000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38073000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-7151000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-7151000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30575000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27482000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20292000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78349000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33125000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5260000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,661000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4522000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37647000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37647000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37647000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37647000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136811000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28932000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28932000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28920000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30346000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26641000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56987000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28067000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5220000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5155000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33222000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33222000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33222000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33222000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,138400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,138400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,141278000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:45:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27744000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27744000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27744000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32955000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28648000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8150000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69753000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42009000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5874000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-208000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6011000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48020000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48020000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48020000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48020000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,141200000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141200000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142098000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:26:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39572000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39572000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39572000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30439000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25830000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9488000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65757000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26185000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10021000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,156000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11340000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21205000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47390000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47390000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47390000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47390000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,143600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142473000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q3,2015-07-01,2015-09-30,2015-11-05 16:37:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53307000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53307000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53307000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31507000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27627000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59134000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5827000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9981000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,151000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1620000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8210000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14037000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142155000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66042000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66042000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66042000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36168000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31842000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68010000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1968000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9907000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,221000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1643000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11329000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,147700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,147700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143593000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54350000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54350000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,54350000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36918000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31682000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1065000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69665000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15315000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9827000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,295000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3145000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6387000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21702000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21702000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21702000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21702000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,144700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,144700000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,144642000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:56:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66106000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66106000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66106000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44987000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37526000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3213000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8667000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94393000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28287000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9765000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,307000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4541000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4917000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33204000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33204000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33204000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33204000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,144400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,144400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145180000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:06:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87459000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87459000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1868000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1868000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85591000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55208000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38442000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-3297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,374000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1164000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91891000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9654000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,346000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2103000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7205000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13505000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13505000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13505000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13505000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145900000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145900000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,144928000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52166000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52166000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,531000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,531000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51635000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55604000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33702000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,420000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1614000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91340000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39705000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10992000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,395000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2199000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12796000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52501000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52501000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52501000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52501000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,147786000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 16:06:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65077000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65077000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3502000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3502000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61575000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57792000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37344000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,421000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,96000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6933000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102586000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41011000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9046000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,496000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5337000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3213000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44224000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,147400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,147400000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,148778000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:06:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,86825000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,86825000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6080000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6080000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80745000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61774000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37065000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1897000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,71000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-628000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100179000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19434000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9135000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,601000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4329000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12863000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32297000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,146800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,146800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,149502000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2017.0,Q3,2017-07-01,2017-09-30,2017-11-02 16:06:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69155000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69155000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2607000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2607000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66548000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59501000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36505000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3476000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2422000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,512000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102416000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35868000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9273000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,681000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1316000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7276000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43144000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43144000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43144000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43144000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,148800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,148800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,151013000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81106000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81106000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4065000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4065000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77041000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59771000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23187000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3476000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1836000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1500000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1962000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91732000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14677000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9383000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,732000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-809000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9460000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24137000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24137000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-25243000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49380000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49380000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,154300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,154300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,152163000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 17:17:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65686000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65686000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4616000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4616000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61070000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50536000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29158000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1159000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1589000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,151794000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10102000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-33519000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,207641000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-146571000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9482000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,741000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3489000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5252000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-151823000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-151823000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-22528000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-174351000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-174351000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,152900000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.14
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,152900000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.14
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153227000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.14
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68730000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68730000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1043000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1043000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67687000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49095000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32198000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3328000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84621000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16934000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9592000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,736000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3944000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4912000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21846000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21846000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-37438000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59284000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59284000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,154956000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,154956000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156000000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:27:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102215000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102215000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11313000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11313000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90902000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43246000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28758000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3169000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,500000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69335000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21577000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9430000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,668000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-532000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9294000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12283000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12283000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12300000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,155849000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 17:17:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,131167000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,131167000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,506000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,506000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,130661000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40919000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27551000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3530000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-166000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64774000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65887000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41434000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,893000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4698000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45239000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20648000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20648000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20648000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20648000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,158800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,158800000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156436000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126301000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126301000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11013000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11013000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,115288000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39190000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26537000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-42000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65685000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49593000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7123000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,565000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4823000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1735000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47858000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47858000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47841000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47841000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153600000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156023000.0
Ironwood Pharmaceuticals Inc,IRWD,,0001446847,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
